Показано 0 из 0
Дата |
---|
03.05.2024 |
29.04.2024 |
18.04.2024 |
17.04.2024 |
16.04.2024 |
15.04.2024 |
11.04.2024 |
10.04.2024 |
05.04.2024 |
04.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.0117
|
0.0218
|
0.016
|
0.016
|
0.0218
|
0.0218
|
|
|
37.80
|
4.00
|
0.0117
|
0.0299
|
0.022
|
0.022
|
0.0221
|
0.022
|
|
|
576.48
|
11.00
|
0.0117
|
0.027
|
0.015
|
0.015
|
0.015
|
0.015
|
|
|
15.28
|
2.00
|
0.0117
|
0.0299
|
0.0121
|
0.0116
|
0.0121
|
0.0116
|
|
|
23.35
|
2.00
|
0.0113
|
0.024
|
0.0115
|
0.0115
|
0.025
|
0.025
|
|
|
21.57
|
2.00
|
0.0113
|
0.027
|
0.0298
|
0.028
|
0.0299
|
0.028
|
|
|
483.57
|
11.00
|
0.0113
|
0.0299
|
0.0126
|
0.0114
|
0.0135
|
0.0135
|
|
|
1 002.22
|
12.00
|
0.0113
|
0.0299
|
0.0155
|
0.0113
|
0.0155
|
0.0121
|
|
|
2 262.18
|
31.00
|
0.015
|
0.03
|
0.0164
|
0.0153
|
0.0164
|
0.015323
|
|
|
66.99
|
4.00
|
0.0113
|
0.03
|
0.013
|
0.013
|
0.015
|
0.015
|
|
|
1 367.50
|
8.00
|
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.